CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Provision for Loan and Lease Losses
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Provision for Loan and Lease Losses of $6.71 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-22.
Discontinued › Notes
us-gaap:ProvisionForLoanAndLeaseLosses · last filed 2023-02-22
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. provision for loan and lease losses for fiscal 2022 was $6.71M, a 304.71% increase from fiscal 2021.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. provision for loan and lease losses for fiscal 2021 was $1.66M, a 74.01% decline from fiscal 2020.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. provision for loan and lease losses for fiscal 2020 was $6.38M.
| Period end | Provision for Loan and Lease Losses 12 month |
|---|---|
| 2022-12-31 | $6.71M 10-K · filed 2023-02-22 |
| 2021-12-25 | $1.66M 10-K · filed 2023-02-22 |
| 2020-12-26 | $6.38M 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |